A Study to Evaluate Patient Experiences with Pharmacogenomic-Based Individualized Medicine

Overview

About this study

The purpose of this study is to investigate understanding, retention, concerns, and expectations of individuals engaged in the process of utilizing pharmacogenomic testing as a clinical tool.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Competent 
  • Able to provide Written Consent (Arm 1) or Oral Consent (Arm 2)

Exclusion Criteria: 

  • Non-competent 
  • Under the age of 18 
  • Patient refusal to participate in research studies at Mayo Clinic

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Sanjay Bagaria, M.D.

Open for enrollment

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20423502

Mayo Clinic Footer